T.R.U.E. TEST
Commercial- Indications
- Allergic contact dermatitis diagnosis
Company intelligence / Profile preview
SmartPractice Denmark
Hillerød, Hovedstaden, Denmarkfda.gov ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SmartPractice Denmark (formerly Mekos Laboratories) is a leading developer and manufacturer of diagnostic patch tests for allergic contact dermatitis. Its flagship product, T.R.U.E. TEST®, is FDA-approved and widely used globally for standardized patch testing to identify specific allergens responsible for contact allergies[1][2][6]. Clinical studies have validated the test’s efficacy in diagnosing reactions to various allergens[3].
- Therapeutic areas
- Dermatology
- Modalities
- Device
- Industry
- Metabolite Diagnostics
02
Drug pipeline
1 assetBeyond the preview
Go deeper on SmartPractice Denmark.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SmartPractice Denmark.